Justin McCue
Senior VP & Chief Technology OfficerDr. Justin McCue, Ph.D., is Senior VP & Chief Technology Officer of Akebia Therapeutics, Inc. from March 2026. Dr. McCue served as the Chief Technology Officer of TScan Therapeutics, Inc. from December, 2023 until 2025. Dr. McCue joins TScan with experience in biologics and cell therapy manufacturing, including process/analytical development, technical operations, clinical development and commercialization of T cell therapy products. He served as Chief Technology Officer of Avectas Limited from August 2022 and also served as its Member of Advisory Board since September 2022. Prior to joining Avectas, Dr. McCue was Vice President of Technical Operations at Repertoire Immune Medicines where he led CMC development and clinical manufacturing of their multi-targeted antigen-specific T-cell platform. Before this, Dr. McCue spent more years in the cell therapy and biopharma industry, including roles at Juno/Celgene and Biogen. Most recently, he was Vice President of Technical Operations at Repertoire Immune Medicines where he led CMC development and clinical manufacturing of their multi-targeted antigen-specific T-cell platform. He served as Vice President of Chemistry, Manufacturing and Controls of Omeros Corporation since December 3, 2018. Dr. McCue oversees for Omeros all development, manufacturing and supply of both biological and small-molecule drugs. Dr. McCue joins Omeros from Celgene where he headed the development of CAR T-cell and T-cell receptor (TCR) therapy manufacturing processes. Prior to Celgene, he led Biogen’s CMC activities for the multi-billion-dollar drugs AVONEX® and PLEGRIDY®, approved for the treatment of multiple sclerosis in more than 90 countries. He began his career in the biopharmaceutical division at Millipore. Dr. McCue earned his Ph.D. and completed a post-doctoral fellowship in Chemical Engineering at Massachusetts Institute of Technology (M.I.T.) after receiving a Bachelor's in Chemical Engineering at University of California at Berkeley.
Positions
- Company NameAkebia Therapeutics, Inc.Stock CodeAKBAPositionSenior VP & Chief Technology OfficerColleagues
- JPJohn P. ButlerCEO, President & Director
- AAAdrian AdamsIndependent Chairperson
- EJErik John OstrowskiChief Business Officer, Senior VP, CFO & Treasurer
- SKSteven Keith BurkeSenior VP and Chief Research & Development Officer
- RCRichard C. MalabreSenior VP & Chief Accounting Officer
- CSCynthia SmithIndependent Director
- MWMichael W. RogersIndependent Director
- RERonald E. FriesonIndependent Director
